Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -6.70% | |
| Bollinger Band Squeeze | Range Contraction | -6.70% | |
| NR7 | Range Contraction | -6.70% | |
| BB Squeeze Started | Range Contraction | -6.70% | |
| 20 DMA Support | Bullish | -6.00% | |
| 20 DMA Support | Bullish | -6.93% |
| Alert | Time |
|---|---|
| 50 DMA Support | about 5 hours ago |
| Lower Bollinger Band Support | about 5 hours ago |
| Down 10% | about 5 hours ago |
| Down 1 ATR | about 5 hours ago |
| 10 DMA Resistance | about 10 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Cardiovascular Disease Hypertension Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Cardiovascular Disease Hypertension Neuromodulation Artery Disease Coronary Artery Disease Angioplasty Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.68 |
| 52 Week Low | 4.22 |
| Average Volume | 154,402 |
| 200-Day Moving Average | 6.55 |
| 50-Day Moving Average | 7.26 |
| 20-Day Moving Average | 7.98 |
| 10-Day Moving Average | 8.14 |
| Average True Range | 0.61 |
| RSI (14) | 46.52 |
| ADX | 13.27 |
| +DI | 14.71 |
| -DI | 25.68 |
| Chandelier Exit (Long, 3 ATRs) | 7.03 |
| Chandelier Exit (Short, 3 ATRs) | 8.28 |
| Upper Bollinger Bands | 8.69 |
| Lower Bollinger Band | 7.26 |
| Percent B (%b) | 0.18 |
| BandWidth | 17.90 |
| MACD Line | 0.20 |
| MACD Signal Line | 0.30 |
| MACD Histogram | -0.1002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.16 | ||||
| Resistance 3 (R3) | 9.19 | 8.68 | 8.88 | ||
| Resistance 2 (R2) | 8.68 | 8.26 | 8.66 | 8.79 | |
| Resistance 1 (R1) | 8.10 | 8.01 | 7.85 | 8.07 | 8.70 |
| Pivot Point | 7.59 | 7.59 | 7.46 | 7.57 | 7.59 |
| Support 1 (S1) | 7.01 | 7.17 | 6.76 | 6.98 | 6.34 |
| Support 2 (S2) | 6.50 | 6.92 | 6.48 | 6.25 | |
| Support 3 (S3) | 5.92 | 6.50 | 6.16 | ||
| Support 4 (S4) | 5.89 |
